Cargando…

A pooled analysis of mesenchymal stem cell-based therapy for liver disease

BACKGROUND: Liver disease is a major cause of death and disability. Mesenchymal stem cells (MSCs) show promise for the treatment of liver disease. However, whether MSC-based therapy is more effective than conventional treatment is unclear, as are the optimal MSC source, the administration frequency,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Lu, Chen, Shanquan, Shi, Xiaowei, Cao, Hongcui, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863358/ https://www.ncbi.nlm.nih.gov/pubmed/29562935 http://dx.doi.org/10.1186/s13287-018-0816-2

Ejemplares similares

The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
por: Zhao, Lu, et al.
Publicado: (2019)

Pooled Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicle Therapy for Liver Disease in Preclinical Models
por: Fang, Xinru, et al.
Publicado: (2023)

Immunomodulatory effect of mesenchymal stem cells in chemical-induced liver injury: a high-dimensional analysis
por: Liu, Jingqi, et al.
Publicado: (2019)

Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure
por: Wang, Jie, et al.
Publicado: (2017)

Characteristics of Intestinal Microecology during Mesenchymal Stem Cell-Based Therapy for Mouse Acute Liver Injury
por: Dong, Xiaotian, et al.
Publicado: (2019)

Porcine Adipose-Derived Mesenchymal Stem Cells Retain Their Stem Cell Characteristics and Cell Activities While Enhancing the Expression of Liver-Specific Genes after Acute Liver Failure
por: Hu, Chenxia, et al.
Publicado: (2016)

Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury
por: Lin, Feiyan, et al.
Publicado: (2022)

Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats
por: Yu, Jiong, et al.
Publicado: (2017)

Recovery Dynamics of Intestinal Bacterial Communities of CCl(4)-Treated Mice with or without Mesenchymal Stem Cell Transplantation over Different Time Points
por: Xu, Yanping, et al.
Publicado: (2020)

The Impact of GFP Reporter Gene Transduction and Expression on Metabolomics of Placental Mesenchymal Stem Cells Determined by UHPLC-Q/TOF-MS
por: Yang, Jinfeng, et al.
Publicado: (2017)

Mesenchymal stem cell-mediated immunomodulation of recruited mononuclear phagocytes during acute lung injury: a high-dimensional analysis study
por: Liu, Jingqi, et al.
Publicado: (2021)

Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure
por: Cao, Hongcui, et al.
Publicado: (2012)

Immunosuppressive effect of mesenchymal stem cells on lung and gut CD8(+) T cells in lipopolysaccharide‐induced acute lung injury in mice
por: Xu, Yanping, et al.
Publicado: (2021)

Mesenchymal stem cells alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of Ly6C(+) CD8(+) T cells
por: Zhu, Jiaqi, et al.
Publicado: (2020)

Immunosuppressive effects of mesenchymal stem cells on lung B cell gene expression in LPS-induced acute lung injury
por: Feng, Bing, et al.
Publicado: (2020)

Human placenta mesenchymal stem cell-derived exosomes delay H(2)O(2)-induced aging in mouse cholangioids
por: Chen, Wenyi, et al.
Publicado: (2021)

Impact of Total Epinephrine Dose on Long Term Neurological Outcome for Cardiac Arrest Patients: A Cohort Study
por: Shi, Xiaowei, et al.
Publicado: (2021)

Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Hypoxia-inducible factor-2 alpha promotes the proliferation of human placenta-derived mesenchymal stem cells through the MAPK/ERK signaling pathway
por: Zhu, Chengxing, et al.
Publicado: (2016)

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues
por: Yang, Ya, et al.
Publicado: (2021)

Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease
por: Yuan, Mengqin, et al.
Publicado: (2022)

Mesenchymal stem cells-based therapy in liver diseases
por: Han, Heng-Tong, et al.
Publicado: (2022)

Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

C-Reactive Protein Is an Independent Predictor of 30-Day Bacterial Infection Post-Liver Transplantation
por: Yu, Jiong, et al.
Publicado: (2021)

Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
por: Cao, Yan, et al.
Publicado: (2020)

Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
por: Zhang, Sainan, et al.
Publicado: (2020)

Mesenchymal stem cells shift the pro-inflammatory phenotype of neutrophils to ameliorate acute lung injury
por: Feng, Bing, et al.
Publicado: (2023)

The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Zhang, Yazhen, et al.
Publicado: (2020)

Comparative transcriptome analysis of peripheral blood mononuclear cells in hepatitis B-related acute-on-chronic liver failure
por: Zhou, Qian, et al.
Publicado: (2016)

The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation
por: Hu, Chenxia, et al.
Publicado: (2019)

Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2(−/−) Mice and Human Intrahepatic Cholangiocyte Organoid Models
por: Yao, Qigu, et al.
Publicado: (2023)

A tryptophan derivative, ITE, enhances liver cell metabolic functions in vitro
por: Zhang, Xiaoqian, et al.
Publicado: (2017)

Characteristics and outcomes of acute-on-chronic liver failure patients with or without cirrhosis using two criteria
por: Dong, Xiaotian, et al.
Publicado: (2020)

Stem cell therapy for Crohn’s disease: systematic review and meta-analysis of preclinical and clinical studies
por: Wang , Ruo, et al.
Publicado: (2021)

Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China
por: Wu, Jian, et al.
Publicado: (2021)

Recurrence of SARS-CoV-2 nucleic acid positive test in patients with COVID-19: a report of two cases
por: Wu, Jian, et al.
Publicado: (2020)

Progress in mesenchymal stem cell–based therapy for acute liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fs5ocj75lb0o3gtol8srr1d5nv